vs
Side-by-side financial comparison of BLUE OWL CAPITAL INC. (OWL) and SELECT MEDICAL HOLDINGS CORP (SEM). Click either name above to swap in a different company.
SELECT MEDICAL HOLDINGS CORP is the larger business by last-quarter revenue ($1.4B vs $755.6M, roughly 1.8× BLUE OWL CAPITAL INC.). BLUE OWL CAPITAL INC. runs the higher net margin — 6.3% vs 1.4%, a 4.9% gap on every dollar of revenue. On growth, BLUE OWL CAPITAL INC. posted the faster year-over-year revenue change (19.7% vs 6.4%). BLUE OWL CAPITAL INC. produced more free cash flow last quarter ($359.1M vs $5.2M). Over the past eight quarters, BLUE OWL CAPITAL INC.'s revenue compounded faster (21.3% CAGR vs 2.8%).
Blue Owl Capital Inc. is an American alternative investment asset management company that is listed on the New York Stock Exchange under the ticker symbol: "OWL". Headquartered in New York City, it has additional offices around the world, including London, Dubai, and Hong Kong.
Select Medical is a healthcare company based in Pennsylvania. It owns long-term acute care and inpatient rehabilitation hospitals, as well as occupational health and physical therapy clinics. Select Medical is a subsidiary of Select Medical Holdings, which is listed on the New York Stock Exchange.
OWL vs SEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $755.6M | $1.4B |
| Net Profit | $47.7M | $20.2M |
| Gross Margin | — | — |
| Operating Margin | 22.2% | 4.6% |
| Net Margin | 6.3% | 1.4% |
| Revenue YoY | 19.7% | 6.4% |
| Net Profit YoY | 129.8% | 225.7% |
| EPS (diluted) | $0.07 | $0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $755.6M | $1.4B | ||
| Q3 25 | $728.0M | $1.4B | ||
| Q2 25 | $703.1M | $1.3B | ||
| Q1 25 | $683.5M | $1.4B | ||
| Q4 24 | $631.4M | $1.3B | ||
| Q3 24 | $600.9M | $1.3B | ||
| Q2 24 | $549.8M | $1.3B | ||
| Q1 24 | $513.3M | $1.3B |
| Q4 25 | $47.7M | $20.2M | ||
| Q3 25 | $6.3M | $28.8M | ||
| Q2 25 | $17.4M | $40.6M | ||
| Q1 25 | $7.4M | $56.7M | ||
| Q4 24 | $20.7M | $-16.1M | ||
| Q3 24 | $29.8M | $55.6M | ||
| Q2 24 | $33.9M | $77.6M | ||
| Q1 24 | $25.1M | $96.9M |
| Q4 25 | 22.2% | 4.6% | ||
| Q3 25 | 7.6% | 5.4% | ||
| Q2 25 | 12.0% | 6.5% | ||
| Q1 25 | 5.9% | 8.3% | ||
| Q4 24 | 11.7% | 1.6% | ||
| Q3 24 | 18.7% | 4.3% | ||
| Q2 24 | 28.4% | 5.8% | ||
| Q1 24 | 24.7% | 9.0% |
| Q4 25 | 6.3% | 1.4% | ||
| Q3 25 | 0.9% | 2.1% | ||
| Q2 25 | 2.5% | 3.0% | ||
| Q1 25 | 1.1% | 4.2% | ||
| Q4 24 | 3.3% | -1.2% | ||
| Q3 24 | 5.0% | 4.4% | ||
| Q2 24 | 6.2% | 6.1% | ||
| Q1 24 | 4.9% | 7.3% |
| Q4 25 | $0.07 | $0.17 | ||
| Q3 25 | $0.01 | $0.23 | ||
| Q2 25 | $0.02 | $0.32 | ||
| Q1 25 | $0.00 | $0.44 | ||
| Q4 24 | $0.06 | $-0.12 | ||
| Q3 24 | $0.04 | $0.43 | ||
| Q2 24 | $0.06 | $0.60 | ||
| Q1 24 | $0.04 | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $194.5M | $26.5M |
| Total DebtLower is stronger | $3.3B | $1.8B |
| Stockholders' EquityBook value | $2.2B | $1.7B |
| Total Assets | $12.5B | $5.9B |
| Debt / EquityLower = less leverage | 1.51× | 1.06× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $194.5M | $26.5M | ||
| Q3 25 | $137.3M | $60.1M | ||
| Q2 25 | $117.6M | $52.3M | ||
| Q1 25 | $97.6M | $53.2M | ||
| Q4 24 | $152.1M | $59.7M | ||
| Q3 24 | $115.9M | $191.5M | ||
| Q2 24 | $436.8M | $111.2M | ||
| Q1 24 | $155.8M | $92.6M |
| Q4 25 | $3.3B | $1.8B | ||
| Q3 25 | $3.2B | $1.7B | ||
| Q2 25 | $3.2B | $1.8B | ||
| Q1 25 | $3.2B | $1.8B | ||
| Q4 24 | $2.6B | $1.7B | ||
| Q3 24 | $2.5B | $3.1B | ||
| Q2 24 | $2.5B | $3.6B | ||
| Q1 24 | $2.1B | $3.8B |
| Q4 25 | $2.2B | $1.7B | ||
| Q3 25 | $2.3B | $1.7B | ||
| Q2 25 | $2.4B | $1.7B | ||
| Q1 25 | $2.3B | $1.7B | ||
| Q4 24 | $2.1B | $1.7B | ||
| Q3 24 | $2.0B | $1.9B | ||
| Q2 24 | $1.7B | $1.4B | ||
| Q1 24 | $1.6B | $1.4B |
| Q4 25 | $12.5B | $5.9B | ||
| Q3 25 | $12.5B | $5.7B | ||
| Q2 25 | $12.3B | $5.7B | ||
| Q1 25 | $12.3B | $5.7B | ||
| Q4 24 | $11.0B | $5.6B | ||
| Q3 24 | $10.8B | $8.0B | ||
| Q2 24 | $9.7B | $7.9B | ||
| Q1 24 | $9.0B | $7.9B |
| Q4 25 | 1.51× | 1.06× | ||
| Q3 25 | 1.41× | 1.03× | ||
| Q2 25 | 1.38× | 1.10× | ||
| Q1 25 | 1.37× | 1.03× | ||
| Q4 24 | 1.22× | 1.01× | ||
| Q3 24 | 1.27× | 1.62× | ||
| Q2 24 | 1.41× | 2.54× | ||
| Q1 24 | 1.26× | 2.75× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $382.9M | $64.3M |
| Free Cash FlowOCF − Capex | $359.1M | $5.2M |
| FCF MarginFCF / Revenue | 47.5% | 0.4% |
| Capex IntensityCapex / Revenue | 3.1% | 4.2% |
| Cash ConversionOCF / Net Profit | 8.03× | 3.19× |
| TTM Free Cash FlowTrailing 4 quarters | $1.2B | $117.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $382.9M | $64.3M | ||
| Q3 25 | $433.1M | $175.3M | ||
| Q2 25 | $422.5M | $110.3M | ||
| Q1 25 | $17.6M | $-3.5M | ||
| Q4 24 | $324.0M | $125.4M | ||
| Q3 24 | $326.0M | $181.0M | ||
| Q2 24 | $302.3M | $278.2M | ||
| Q1 24 | $47.2M | $-66.7M |
| Q4 25 | $359.1M | $5.2M | ||
| Q3 25 | $422.5M | $122.2M | ||
| Q2 25 | $412.5M | $45.6M | ||
| Q1 25 | $4.2M | $-55.8M | ||
| Q4 24 | $310.1M | $62.0M | ||
| Q3 24 | $314.8M | $130.3M | ||
| Q2 24 | $269.4M | $222.6M | ||
| Q1 24 | $41.1M | $-119.2M |
| Q4 25 | 47.5% | 0.4% | ||
| Q3 25 | 58.0% | 9.0% | ||
| Q2 25 | 58.7% | 3.4% | ||
| Q1 25 | 0.6% | -4.1% | ||
| Q4 24 | 49.1% | 4.7% | ||
| Q3 24 | 52.4% | 10.2% | ||
| Q2 24 | 49.0% | 17.4% | ||
| Q1 24 | 8.0% | -9.0% |
| Q4 25 | 3.1% | 4.2% | ||
| Q3 25 | 1.5% | 3.9% | ||
| Q2 25 | 1.4% | 4.8% | ||
| Q1 25 | 2.0% | 3.9% | ||
| Q4 24 | 2.2% | 4.8% | ||
| Q3 24 | 1.9% | 4.0% | ||
| Q2 24 | 6.0% | 4.3% | ||
| Q1 24 | 1.2% | 4.0% |
| Q4 25 | 8.03× | 3.19× | ||
| Q3 25 | 68.64× | 6.09× | ||
| Q2 25 | 24.25× | 2.72× | ||
| Q1 25 | 2.37× | -0.06× | ||
| Q4 24 | 15.62× | — | ||
| Q3 24 | 10.94× | 3.25× | ||
| Q2 24 | 8.91× | 3.59× | ||
| Q1 24 | 1.88× | -0.69× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OWL
| Credit Platform | $455.0M | 60% |
| GP Strategic Capital Platform | $157.0M | 21% |
| Administrative Service | $87.6M | 12% |
| IPI Partners LLC | $33.8M | 4% |
| Other | $22.2M | 3% |
SEM
| Critical Illness Recovery Hospitals | $629.7M | 45% |
| Health Care Patient Service Non Medicare | $428.6M | 31% |
| Rehabilitation Hospitals | $339.2M | 24% |
